Biopharma Co. Hit With Investor Action Over COVID Treatment

Eiger BioPharmaceuticals Inc. was hit with a proposed class action in California federal court on Tuesday by an investor who claims the company overstated the likelihood that its experimental treatment for...

Already a subscriber? Click here to view full article